List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 4 studies with search of: Forodesine AND CTCL
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Forodesine in the Treatment of Cutaneous T-Cell Lymphoma
Condition: Cutaneous T-cell Lymphoma (CTCL),
Intervention: Drug: Forodesine 200 mg
2 Active, not recruiting Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma
Condition: Lymphoma
Intervention: Drug: forodesine hydrochloride
3 Completed BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma
Condition: Lymphoma
Intervention: Drug: forodesine hydrochloride
4 Completed BCX-1777 in Treating Patients With Refractory Cancer
Condition: Cancer
Intervention: Drug: forodesine hydrochloride

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services